CompoAtlas

Ganoderma Spore Capsules

Natural health product licensed in Canada

Other names
Ganoderma Spore 400 mg Capsules
Licence holder
PhytoCanada Inc.
NPN or DIN-HM
80065440
Status
Active licence
Licence date
24 November 2015
Revision date
Not provided
Form
Capsule, dur
Route of administration
Orale
Application type
Officinale

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Ganoderma lucidum

Source : Spore(s)

400 milligrammeNot calculated

Non-medicinal ingredients

Gélatine

PopulationAgeQuantity per servingFrequency
Adultesminimum: 18 years3 Capsule2 Tous les jours

Uses authorised in Canada

(1) Used in Traditional Chinese Medicine (TCM) to dispel phlegm, stop cough and arrest wheezing. (2) Used in Traditional Chinese Medicine (TCM) to nourish the Heart and strengthen qi and blood to treat Heart and Spleen deficiencies that manifest in insomnia, forgetfulness, fatigue, listlessness and poor appetite. (3) Used in Traditional Chinese Medicine (TCM) to strengthen the body and tonify qi. (4) Source of/Provides antioxidants. (5) Used in Herbal Medicine as a liver tonic. (6) Used in Herbal Medicine as an adaptogen to help increase energy and resistance to stress (in case of mental and physical fatigue related to stress). (7) Source of fungal polysaccharides with immunomodulating properties.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80065440

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line